Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$335M |
| 2 |
Amazon
AMZN
|
+$287M |
| 3 |
Otis Worldwide
OTIS
|
+$260M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$720M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$365M |
| 3 |
RTN
Raytheon Company
RTN
|
+$357M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$212M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.87% |
| 2 | Healthcare | 13.57% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.73% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
AdaptHealth
AHCO
$1.47B
| $556K | ﹤0.01% |
+34,494
| New | +$576K |
|
|
DLA
3527
DELISTED
Delta Apparel Inc.
DLA
| $556K | ﹤0.01% |
45,870
-56,454
| -55% | -$645K |
|
3528
Kura Sushi USA
KRUS
$560M
| $551K | ﹤0.01% |
38,563
-6,414
| -14% | -$91.9K |
|
|
TRQ
3529
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $550K | ﹤0.01% |
74,994
-5,022
| -6% | -$29.6K |
|
3530
Atomera
ATOM
$200M
| $549K | ﹤0.01% |
61,018
+36,318
| +147% | +$249K |
|
3531
Champions Oncology
CSBR
$74.5M
| $548K | ﹤0.01% |
57,278
+29,931
| +109% | +$255K |
|
|
CMBM
3532
DELISTED
Cambium Networks
CMBM
| $546K | ﹤0.01% |
74,272
-674
| -0.9% | -$3.75K |
|
3533
Value Line
VALU
$321M
| $543K | ﹤0.01% |
20,109
-4,656
| -19% | -$133K |
|
3534
Schwab US Dividend Equity ETF
SCHD
$103B
| $542K | ﹤0.01% |
31,398
-693
| -2% | -$11.7K |
|
|
CEMI
3535
DELISTED
Chembio diagnostics, Inc.
CEMI
| $539K | ﹤0.01% |
166,067
+120,583
| +265% | +$1.14M |
|
|
HDV
3536
iShares Core High Dividend ETF
HDV
$14.5B
| $535K | ﹤0.01% |
32,955
+4,355
| +15% | +$70.3K |
|
|
BXG
3537
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
| $533K | ﹤0.01% |
98,371
-8,038
| -8% | -$38.3K |
|
|
3538
Schwab US Broad Market ETF
SCHB
$43.2B
| $530K | ﹤0.01% |
43,248
-18,350,802
| -100% | -$212M |
|
3539
Bogota Financial
BSBK
$116M
| $528K | ﹤0.01% |
+60,372
| New | +$506K |
|
|
SREV
3540
DELISTED
ServiceSource International, Inc.
SREV
| $527K | ﹤0.01% |
334,045
+133,765
| +67% | +$183K |
|
|
NIU
3541
Niu Technologies
NIU
$203M
| $522K | ﹤0.01% |
+32,615
| New | +$328K |
|
3542
Globalstar
GSAT
$10.7B
| $520K | ﹤0.01% |
105,883
-2,763
| -3% | -$13.1K |
|
3543
Revolve Group
RVLV
$1.8B
| $520K | ﹤0.01% |
34,987
+1,887
| +6% | +$24.8K |
|
3544
Woori Financial
WF
$16.7B
| $519K | ﹤0.01% |
23,417
-75,327
| -76% | -$1.58M |
|
|
OPNT
3545
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $519K | ﹤0.01% |
57,383
+10,303
| +22% | +$107K |
|
|
GSB
3546
DELISTED
GlobalSCAPE, Inc.
GSB
| $514K | ﹤0.01% |
52,734
+29,317
| +125% | +$271K |
|
3547
Intellicheck
IDN
$73.1M
| $501K | ﹤0.01% |
66,310
+42,722
| +181% | +$259K |
|
3548
Kodak
KODK
$822M
| $501K | ﹤0.01% |
225,191
+156,502
| +228% | +$364K |
|
3549
Suzano
SUZ
$10.5B
| $501K | ﹤0.01% |
74,170
-77,746
| -51% | -$567K |
|
|
OXFD
3550
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $498K | ﹤0.01% |
38,256
-7,740
| -17% | -$93K |
|
Similar funds
Northern Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Northern Trust held 4,386 positions worth $422B, up 21% from $348B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Northern Trust's Q2 2020 filing shows 169 new, 2,281 increased, 1,710 reduced and 126 closed positions. Its largest new stake was Otis Worldwide: 5,015,118 shares worth $285M. The largest sale was Allergan plc, an estimated $720M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q2 2020 buy was Otis Worldwide: 5,015,118 shares worth $285M.
- Northern Trust added most to AbbVie in Q2 2020, an estimated $335M increase.
- Northern Trust's biggest Q2 2020 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $365M.
- Northern Trust fully exited Allergan plc in Q2 2020, selling an estimated $720M.
- Northern Trust's ten largest holdings make up 21% of its $422B portfolio in Q2 2020.
- Northern Trust opened 169 new positions and closed 126 in Q2 2020.
- Northern Trust's portfolio value rose 21% quarter-over-quarter to $422B.
Based on Northern Trust's 13F filing for Q2 2020, filed 14 Aug 2020.